Trial Details
COMPLETEDBasic Information
| Clinical ID | c1380 |
|---|---|
| Identifier | NCT05130047 |
| Trial Title | Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Chronic Diarrhea|Irritable Bowel Syndrome With Diarrhea|Bile Acid Malabsorption|Bile Acid Diarrhea|Bile Acid Malabsorption Syndrome Type II|Functional Diarrhea |
| Interventions | DRUG: Aldafermin|DRUG: Placebo |
Participant Information
| Sponsor | Michael Camilleri, MD |
|---|---|
| City | Rochester |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2021-12-01 |
|---|---|
| Primary Completion Date | 2022-11-08 |
| Completion Date | 2022-11-08 |